BR0308472A - Processo para preparar a forma i cristalina de cabergolina - Google Patents
Processo para preparar a forma i cristalina de cabergolinaInfo
- Publication number
- BR0308472A BR0308472A BR0308472-8A BR0308472A BR0308472A BR 0308472 A BR0308472 A BR 0308472A BR 0308472 A BR0308472 A BR 0308472A BR 0308472 A BR0308472 A BR 0308472A
- Authority
- BR
- Brazil
- Prior art keywords
- cabergoline
- toluene
- preparing crystalline
- cabergoline form
- mixture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36456702P | 2002-03-15 | 2002-03-15 | |
US41025302P | 2002-09-12 | 2002-09-12 | |
PCT/US2003/007138 WO2003078392A2 (en) | 2002-03-15 | 2003-03-10 | Process for preparing crystalline form i of cabergoline |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0308472A true BR0308472A (pt) | 2005-01-11 |
Family
ID=28045415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0308472-8A BR0308472A (pt) | 2002-03-15 | 2003-03-10 | Processo para preparar a forma i cristalina de cabergolina |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1507777A4 (ko) |
JP (1) | JP2005520831A (ko) |
KR (1) | KR100605794B1 (ko) |
CN (1) | CN1642953A (ko) |
AU (1) | AU2003224665A1 (ko) |
BR (1) | BR0308472A (ko) |
CA (1) | CA2478149A1 (ko) |
IL (1) | IL163779A0 (ko) |
MX (1) | MXPA04008935A (ko) |
PL (1) | PL372371A1 (ko) |
RS (1) | RS77704A (ko) |
RU (1) | RU2277536C2 (ko) |
TW (1) | TW200306312A (ko) |
WO (1) | WO2003078392A2 (ko) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL155545A (en) | 2003-04-21 | 2009-12-24 | Finetech Pharmaceutical Ltd | Solvate form of cabergoline |
EP1620101A4 (en) * | 2003-05-08 | 2008-07-09 | Ivax Pharmaceuticals Sro | POLYMORPHS OF CABERGOLIN |
GB0409785D0 (en) * | 2004-04-30 | 2004-06-09 | Resolution Chemicals Ltd | Preparation of cabergoline |
GB0515430D0 (en) * | 2005-07-27 | 2005-08-31 | Resolution Chemicals Ltd | Preparation of cabergoline |
GB0505965D0 (en) | 2005-03-23 | 2005-04-27 | Resolution Chemicals Ltd | Preparation of cabergoline |
US7339060B2 (en) * | 2005-03-23 | 2008-03-04 | Resolution Chemicals, Ltd. | Preparation of cabergoline |
EP1953157A1 (en) | 2007-01-31 | 2008-08-06 | LEK Pharmaceuticals D.D. | New crystal form of cabergoline |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4526892A (en) * | 1981-03-03 | 1985-07-02 | Farmitalia Carlo Erba, S.P.A. | Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas |
GB0007308D0 (en) * | 2000-03-24 | 2000-05-17 | Pharmacia & Upjohn Spa | Process for preparing crystalline form | of cabergoline |
IL163520A0 (en) * | 2002-03-15 | 2005-12-18 | Pharmacia Italia Spa | Process for preparing crystalline form i of cabergoline |
-
2003
- 2003-03-10 MX MXPA04008935A patent/MXPA04008935A/es not_active Application Discontinuation
- 2003-03-10 CA CA002478149A patent/CA2478149A1/en not_active Abandoned
- 2003-03-10 PL PL03372371A patent/PL372371A1/xx not_active Application Discontinuation
- 2003-03-10 AU AU2003224665A patent/AU2003224665A1/en not_active Abandoned
- 2003-03-10 KR KR1020047014429A patent/KR100605794B1/ko not_active IP Right Cessation
- 2003-03-10 JP JP2003576398A patent/JP2005520831A/ja active Pending
- 2003-03-10 IL IL16377903A patent/IL163779A0/xx unknown
- 2003-03-10 RS YU77704A patent/RS77704A/sr unknown
- 2003-03-10 CN CNA038061309A patent/CN1642953A/zh active Pending
- 2003-03-10 RU RU2004127582/04A patent/RU2277536C2/ru not_active IP Right Cessation
- 2003-03-10 EP EP03721346A patent/EP1507777A4/en not_active Withdrawn
- 2003-03-10 BR BR0308472-8A patent/BR0308472A/pt not_active IP Right Cessation
- 2003-03-10 WO PCT/US2003/007138 patent/WO2003078392A2/en not_active Application Discontinuation
- 2003-03-13 TW TW092105467A patent/TW200306312A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP1507777A4 (en) | 2007-03-07 |
WO2003078392A3 (en) | 2003-12-11 |
RS77704A (en) | 2006-10-27 |
MXPA04008935A (es) | 2004-11-26 |
RU2277536C2 (ru) | 2006-06-10 |
EP1507777A2 (en) | 2005-02-23 |
CA2478149A1 (en) | 2003-09-25 |
KR100605794B1 (ko) | 2006-08-01 |
KR20050002858A (ko) | 2005-01-10 |
WO2003078392A2 (en) | 2003-09-25 |
AU2003224665A1 (en) | 2003-09-29 |
PL372371A1 (en) | 2005-07-25 |
TW200306312A (en) | 2003-11-16 |
IL163779A0 (en) | 2005-12-18 |
RU2004127582A (ru) | 2006-01-27 |
JP2005520831A (ja) | 2005-07-14 |
CN1642953A (zh) | 2005-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004092126A3 (en) | Process and intermediates for the preparation of pyrrolidine carboxylic acids | |
IL174781A0 (en) | Process for producing bicalutamide and method of purifying intermediate therefor | |
WO2005033121A3 (en) | Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs | |
BR0308472A (pt) | Processo para preparar a forma i cristalina de cabergolina | |
AU2003293585A8 (en) | Intermediate cefdinir salts | |
BR0214209A (pt) | Processo para a preparação de imipenem cristalino e composto preparado pelo dito processo | |
WO2007119118A3 (en) | Synthesis and preparations of intermediates and polymorphs thereof useful for the preparation of donepezil hydrochloride | |
BR0109507A (pt) | Processo para preparação de forma i, cristalina, de carbegolina | |
TW200502205A (en) | The method for purifying vitamin d derivatives and its crystalline products | |
Seo et al. | N-Hydroxymethyl derivatives of α-amino aldehydes used for the stereoselective syntheses of β-amino-α-hydroxy acids | |
CA2572607A1 (en) | Epimerisation of allylic alcohols | |
WO2003048082A3 (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof | |
HUE027821T2 (en) | A method for alkinylation of 16-substituted-17-ketosteroid derivatives | |
CA2291620A1 (en) | Production method of isoxazolidinedione compound | |
Kress et al. | Investigations of the intramolecular Ni (II)/Cr (II)-mediated coupling reaction: Application to the taxane ring system | |
BR0308304A (pt) | Processo para preparar forma i cristalina de cabergolina | |
WO2005080329A3 (en) | Process for manufacture of racemic carvedilol | |
AU707718B2 (en) | A process for the glycosidation of colchicine derivatives and products obtained | |
WO2005058005A3 (en) | Process for synthesizing disulfides | |
Detterbeck et al. | Synthesis and structure elucidation of open-chained putrescine-bisamides from Aglaia species | |
WO2005063731A3 (en) | Production of dihydronepetalactone by reduction of nepetalic acid | |
JPH0641463B2 (ja) | チオテトロン酸の製造方法 | |
WO2006027800A8 (en) | A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine | |
WO2003087070A3 (en) | Growth hormone secretagogues | |
WO2005058796A3 (en) | Processes for preparing venlafaxine and venlafaxine hydrochloride of form i |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A E 7A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010. |